Black Diamond Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.3M | 822k | 2.81 |
| 2023-09-30 | $3.2M | 1.1M | 2.87 |
| 2023-06-30 | $5.5M | 1.1M | 5.05 |
| 2023-03-31 | $1.0k | 552 | 1.81 |
| 2022-12-31 | $1.0k | 552 | 1.81 |
| 2022-06-30 | $4.0k | 1.5k | 2.65 |
| 2022-03-31 | $723k | 261k | 2.78 |
| 2021-12-31 | $1.1M | 198k | 5.33 |
| 2021-03-31 | $8.5M | 352k | 24.19 |
| 2020-12-31 | $12M | 359k | 32.05 |
| 2020-09-30 | $6.2M | 204k | 30.41 |
| 2020-06-30 | $3.1M | 74k | 42.25 |
| 2020-03-31 | $2.5M | 100k | 24.94 |